Hypoglycemia
Conditions
Keywords
type 1 Diabetes, Type 2 Diabetes, Hypoglycemia Biomarkers
Brief summary
The study aims to obtain a panel of biomarkers from hypoglycemic diabetic patients with either type 1 or type 2 diabetics and from control patients with type 1 or type 2 diabetes who didn't have hypoglycemia in the last 72 hours.
Detailed description
Primary endpoint is establishing a panel of biomarkers from 100 hypoglycemic diabetic patients with type 1 or type 2 Diabetes during the incidence of hypoglycemia by taking a single blood sample to be analyzed for HbA1c, LDL, HDL, Triglycerides, CRP, CBC and biochemical analysis including liver and kidney function tests. In addition to 5 ml serum sample to be centrifuged and stored in RCSI lab. Inpatient hypoglycemic patients may also be included in group of hypoglycemia and will be required to have a serial of blood samples taken to be analyzed on the 1st hour, 2nd hour, 3rd hour and 4th hour after the hypoglycemic event. Secondary endpoint involves recruitment of 100 control Diabetic patients with type 1 or type 2 Diabetes to establish a panel of biomarkers by obtaining a blood sample for the HbA1c, LDL, HDL, Triglycerides, CRP, CBC and biochemical analysis including liver and kidney function tests to include 50 subjects fasting overnight and the other 50 subjects to be non-fasting but without having hypoglycemia at the time of recruitment or in the last 72 hours.
Interventions
None listed
Sponsors
King Hamad University Hospital, Bahrain
Royal College of Surgeons in Ireland - Medical University of Bahrain
Study design
Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
Yes
Inclusion criteria
Inclusion criteria for diabetes subjects with hypoglycemia * Diagnosed of type 2 diabetes or type 1 based on the WHO guidelines Patient's age from 21-75 years old * Able to say when the hypo had occurred (free style libre in the outpatient setting, or documented blood glucose less than \< 4 mmol/l (\<70 mg/dl) as an inpatient Inclusion criteria for diabetes subjects without hypoglycemia: * Diagnosed of type 2 diabetes or type 1 based on the WHO guidelines * Patient's age from 21-75 years old * No hypoglycemia or hypoglycemia unawareness.
Exclusion criteria
* eGFR less than 45 ml/min * Liver enzymes 3 folds greater than upper limit * Pregnancy * Patients on steroids or Atypical Antipsychotics or Cyclosporine/Tacrolimus or other medications that may mask hypoglycemia
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Concentrations of a Panel of Protein Biomarkers in hypoglycemic subjects | 1 day from time of presentation | a panel of biomarkers is measured from a blood test taken during the incidence of hypoglycemia from type 1 or type 2 Diabetic subject. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Concentrations of a Panel of Protein Biomarkers Reference Ranges from non-hypoglycemic diabetic subjects | 3 days from time of presentation | a panel of biomarkers is measured from a blood test taken from Diabetic subjects (type 1 or type 2) without having hypoglycemia. |
Other
| Measure | Time frame | Description |
|---|---|---|
| LDL | 1 day from time of presentation | Measured from a blood test taken from Diabetic subjects (type 1 or type 2) control group and hypoglycemic patients |
| HDL | 1 day from time of presentation | Measured from a blood test taken from Diabetic subjects (type 1 or type 2) control group and hypoglycemic patients |
| CBC | 1 day from time of presentation | Measured from a blood test taken from Diabetic subjects (type 1 or type 2) control group and hypoglycemic patients |
| Biochemical analysis | 1 day from time of presentation | Measured from a blood test taken from Diabetic subjects (type 1 or type 2) control group and hypoglycemic patients |
| HbA1C% | 1 day from time of presentation | Measured from a blood test taken from Diabetic subjects (type 1 or type 2) control group and hypoglycemic patients |
| Triglycerides | 1 day from time of presentation | Measured from a blood test taken from Diabetic subjects (type 1 or type 2) control group and hypoglycemic patients |
| CRP | 1 day from time of presentation | Measured from a blood test taken from Diabetic subjects (type 1 or type 2) control group and hypoglycemic patients |
Countries
Bahrain
Outcome results
None listed